Update – 1st Quarter 2015

Update – 1st Quarter 2015
Disclaimer
This presentation is made to provide information. No representation or warranty is made as to
the fairness, accuracy, completeness or correctness of the information, opinions and conclusions
contained within this presentation. All information including business forward plans in this
presentation should not be considered as a recommendation in relation to holding purchasing or
selling shares in any jurisdiction. No copy or use of this presentation should occur without the
permission of PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK.
INTRODUCTION
HIGHLIGHTS (IDR Bn)
Net Sales
Operating Income
% Margin
Earning per Share
Total Asset
Total Liabilities
Equity
Return on Equity
Return on Asset
Current Ratio
Q1'15
Q1'14
Unaudited Unaudited
509
520
138
119
27.2%
23.0%
7.87
7.73
∆
-2.0%
15.9%
4.2%
1.8%
2,906
153
2,753
2,946
205
2,741
-1.4%
-25.1%
0.4%
4.3%
4.1%
12.4
4.2%
3.9%
10.7
0.1%
0.1%
1.66
MILESTONES
The company initially was a domestic herbal
medicine industry managed by Mrs. Rahmat
Sulistio in Yogyakarta.
1940
The limited partnership was formed under
the name CV Industri Jamu & Farmasi Sido
Muncul.
The factory was moved to Lingkungan
Industri Kecil in Jl. Kaliwage, Semarang. In
order to accommodate the growing market
demand, the plant began to be equipped
with modern machinery.
The new factory is located in Klepu, sub
Bergas, Ungaran with an area of about 30
hectares was inaugurated by the Minister of
Health and Social Welfare of the Republic of
Indonesia.
PT Berlico Mulia Farma joined the Sido
Muncul Group, expanding Sido Muncul’s
business in pharmaceutical industry.
1970
1984
2000
2014
1951
The production process was moved to
Semarang, and an unpretentious company
was founded with the name SIDO MUNCUL
which means “a dream come true” with its
first factory located in Jl. Mlaten Trenggulun,
Semarang.
1975
1997
2013
Eshtablishment of herbal medicine industry
turned into a Limited Company under the
name of PT Industri Jamu dan Farmasi Sido
Muncul.
Cornerstone-laying was held for the
construction of a new, bigger and more
modern factory in Klepu, Ungaran by Sri
Sultan Hamengkubuwono X and witnessed
by Director General of Food and Drug
Administration.
Sido Muncul conducted initial
public offering of 1,500,000,000
shares with the issue price of Rp
580.- per share.
KEY ACHIVEMENT
Indonesia WOW Brand 2015
Golden Brand Award 2014 Indonesia Best Brand Award
ICSA 2014 – The Best in Achieving
Total Customer Satisfaction
Ernst & Young Indonesia Family
Business Award Of Excellence 2014
Rising Global Stars Awards 2014
TOP Brand 2014
BUSINESS OVERVIEW
PLANT EXPANSION – PT SEMARANG HERBAL
INDO PLANT (SHIP)
The expansion of SHIP’s new extraction
plant has reached 90% of completion. New
extraction machines are being installed
and will soon start trial production.
The new plant will increase the herbs
extraction capacity up to three times from
current capacity.
DISTRIBUTION – PT MUNCUL MEKAR (MM)
JAKARTA
BLORA
JOMBANG
MM added 2 new distributors in Blora – Central
Java and Jombang – East Java. MM have 110
distributors across Indonesia from 108
distributors in 2013.
MM’s Jakarta representative office
PRODUCT PORTFOLIO
HERBAL
MEDICINE
ENERGY DRINK
BEVERAGE &
CONFECTIONERY
HEALTHY DRINK
PHARMACEUTICAL
SUPPLEMENT &
OTHERS
NEW PRODUCTS – HERBAL MEDICINE
Maintaining and boosting immune system
Relieving muscle stiffness and joint pain
FINANCIAL OVERVIEW
SALES (IDR Bn)
SALES MIX – Q1’15
520.0
Consolidated
-2.0%
509.4
Others
-26.0% (YoY)
Pharmacies
N/A (YoY)
Healthy Drink
-0.8% (YoY)
Bev. & Conf.
-16.6% (YoY)
Energy Drink
-29.0% (YoY)
Herbal Medicine
+13.3% (YoY)
OPERATING PERFORMANCE (IDR Bn)
OPERATING EXPENSES TO SALES
GROSS PROFIT
Consolidated
-0.8%
OPERATING PROFIT MARGIN
NET EARNINGS (IDR Bn)
EBITDA MARGIN
NET INCOME
Consolidated
+1.8%
EBT MARGIN
FINANCIAL POSITION (IDR Bn)
DEBT POSITION
ASSETS & EQUITY
CASH CONVERSION
REMAINING IPO PROCEEDS (IDR BN)
Main Office:
Gedung Menara Suara Merdeka Lantai 16
Jl Pandanaran No.30
Semarang 50134, Indonesia
Phone: (+6224) 7692-8811
Fax: (+6224) 7692-8815
Factory:
Jl Soekarno Hatta km 28
Kecamatan Bergas, Klepu
Semarang 50552, Indonesia
Phone: (+62298) 523-515
Fax: (+62298) 523-509
Website : www.sidomuncul.com
Online Store : www.sidomunculherbal.com
: @Sidomuncul_Corp
: Sidomuncul Corp
APPENDICES
SIDO STRUCTURE
HIDAYAT
FAMILY
PUBLIC
81.00%
99.99%
19.00%
99.99%
99.99%
CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION
in IDR Mn
Current Assets
Cash and Cash Equivalents
Time Deposits
Trade Receivables
Inventories - Net
Others
Total Current Assets
Total Non-current Assets
TOTAL ASSETS
Q1'15
Unaudited
902,622
380,000
273,770
240,413
40,876
1,837,681
1,068,380
2,906,061
2014
Audited
∆
864,791
390,000
322,556
230,736
52,355
1,860,438
960,961
2,821,399
4.4%
-2.6%
-15.1%
4.2%
-21.9%
-1.2%
11.2%
3.0%
CONSOLIDATED STATEMENTS OF FINANCIAL
POSITION
in IDR Mn
Trade Payables
Other Payables
Taxes Payable
Accrued Expenses
Others
Total Current Liabilities
Total Non-current Liabilites
TOTAL LIABILITIES
EQUITY
Equity Attributable to Owners of the Parent Entity
Non-controlling Interest
TOTAL EQUITY
TOTAL LIABILITIES AND EQUITY
Q1'15
Unaudited
110,895
8,583
22,056
5,521
1,618
148,673
4,702
153,375
2014
Audited
137,055
12,472
12,830
17,368
1,706
181,431
5,309
186,740
2,752,680
6
2,752,686
2,906,061
2,634,654
5
2,634,659
2,821,399
∆
-19.1%
-31.2%
71.9%
-68.2%
-5.2%
-18.1%
-11.4%
-17.9%
4.5%
20.0%
4.5%
3.0%
CONSOLIDATED STATEMENTS OF
COMPREHENSIVE INCOME
in IDR Mn
Sales
Cost of Good Sold
Gross Profit
% Margin
Sales and Marketing Expenses
General and Administrative Expenses
Operating Income
% Margin
Other Finance Income
Other Finance Expenses
Other Operating Income
Other Operating Expenses
Income Before Tax
% Margin
Income Tax Expenses
Net Income for the Year
% Margin
Other Comprehensive Income (Loss)
Total Comprehensive Income for the Year
% Margin
Q1'15
Q1'14
Unaudited Unaudited
509,417
520,027
314,799
323,916
194,618
196,111
38.2%
37.7%
33,610
53,455
22,609
23,196
138,399
119,460
27.2%
23.0%
15,037
28,559
284
1,999
2,263
2,196
1,273
1,264
154,142
146,952
30.3%
28.3%
36,116
31,043
118,026
115,909
23.2%
22.3%
118,026
115,909
23.2%
22.3%
∆
-2.0%
-2.8%
-0.8%
0.5%
-37.1%
-2.5%
15.9%
4.2%
-47.3%
-85.8%
3.1%
0.7%
4.9%
2.0%
16.3%
1.8%
0.9%
0.0%
1.8%
0.9%
CONSOLIDATED STATEMENTS OF CASH FLOWS
in IDR Mn
Cash Flows From Operating Activities
Cash Flows From Investing Activities
Cash Flows From Financing Activities
Net Increase (Decrease) in Cash and Cash Equivalents
Effect of Changes in Foreign Exchange Rate
Cash and Cash Equivalents At the Beginning of the Year
Cash and Cash Equivalents At the End of the Year
Q1'15
Q1'14
Unaudited Unaudited
131,872
(14,934)
(94,527)
34,246
37,345
19,312
486
864,791
1,348,955
902,622
1,368,267